Related Experiment Video
Updated: Mar 30, 2026

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
2.0K
Inherent Structure-Based Multiview Learning With Multitemplate Feature Representation for Alzheimer's Disease
IEEE Transactions on Bio-Medical Engineering
|November 6, 2015
Summary
This study introduces a new method for diagnosing Alzheimer's disease (AD) and mild cognitive impairment (MCI) using brain imaging. The approach improves classification accuracy by better understanding data patterns in magnetic resonance imaging scans.
Area of Science:
- Neuroimaging
- Machine Learning
- Medical Diagnostics
Background:
- Multitemplate analysis of brain morphometrics aids Alzheimer's disease (AD) and mild cognitive impairment (MCI) diagnosis.
- Existing methods assume simple data distributions, which may not reflect real-world complexity.
Purpose of the Study:
- To develop an inherent structure-based multiview learning method for improved AD/MCI classification.
- To address limitations of current multitemplate approaches by not assuming pre-defined data distributions.
Main Methods:
- Extracting multiview feature representations using multiple templates.
- Clustering subjects within classes into subclasses and encoding them with unique codes.
- Employing a multitask feature selection model and an ensemble of support vector machine classifiers.
Main Results:
- The proposed method achieves promising results in AD/MCI classification.
- Demonstrated superior performance compared to existing state-of-the-art multitemplate-based methods.
- Validated on the Alzheimer's Disease Neuroimaging Initiative database.
Conclusions:
- The novel inherent structure-based multiview learning method enhances AD/MCI classification accuracy.
- This approach offers a more robust alternative to existing methods by accommodating complex data distributions.
Related Concept Videos
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K

